MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.09.24 Stock

Warrant

DE000MB09UT7

Market Closed - Börse Stuttgart 02:12:56 2024-06-27 pm EDT
0.017 EUR -5.56% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/160/0.1/20.09.24
Current month-5.26%
1 month-10.00%
Date Price Change
24-06-27 0.017 -5.56%
24-06-26 0.018 0.00%
24-06-25 0.018 -5.26%
24-06-24 0.019 +5.56%
24-06-21 0.018 +5.88%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 02:12 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB09UT
ISINDE000MB09UT7
Date issued 2022-11-08
Strike 160 $
Maturity 2024-09-20 (85 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.003
Spread 0.023
Spread %57.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus